23. – 25. 1.
2019
PRAHA
20.–22. 1.2021PRAHA

ZAHRANIČNÍ ÚČAST

 

Prof. Rupert Bartsch, MD

  • Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

 

Prof. Daniele Generali, MD

  • Department of Medical Surgery and Health Sciences, University of Trieste, 34129, Trieste, Italy

 

Dr Filip Janku, MD, PhD

  • Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The university of Texas MD Anderson Cancer Center, USA

 

Prof. Gal Markel MD, PhD

  • Chief Scientist, Head of the Research laboratory at the Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Izrael

 

Jennifer Leigh McQuade, MD, MS, MA

  • Melanoma Medical Oncology, The university of Texas MD Anderson Cancer Center, USA

 

Prof. Dr. Manuela Schmidinger

  • Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

 

Vivek Subbiah, MD

  • Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The university of Texas MD Anderson Cancer Center, USA

 

Eduardo Vilar-Sanchez, MD, PhD

  • Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The university of Texas MD Anderson Cancer Center, USA